Target intelligence / Profile preview

Neurofibromin 1 pseudogene 4 (NF1P4)

Target
NF1P4
Molecular classification
Pseudogene
01

Overview

Neurofibromin 1 pseudogene 4 (NF1P4) is a non-coding pseudogene derived from the functional neurofibromin 1 (NF1) gene. NF1P4 and similar pseudogenes contain sequence resemblance to sections of the NF1 gene but do not encode functional protein products. Pseudogenes such as NF1P4 are distributed on several chromosomes, with some retaining significant homology to portions of the NF1 gene, but they lack important functional domains, such as the GAP-related domain crucial for tumor suppressor function in neurofibromin[2][5]. These pseudogenes are considered genetic relics arising from evolutionary duplication and transposition events and do not have known biological functions, disease associations, or relevance as drug targets. Key points distinguishing pseudogene from functional gene: - Pseudogenes like NF1P4 are non-functional genetic elements and are not considered therapeutic targets, receptors, or enzymes[2][5]. - The functional NF1 gene encodes neurofibromin, a tumor suppressor with a well-established role in regulating Ras/MAPK signaling, but NF1P4 has no such function[1][6]. - There are no disease associations, biological activities, or clinical applications (such as biomarker or drug target) for NF1P4. Summary of validity: NF1P4 is not a therapeutic target, but rather a pseudogene with no protein product or clinical relevance as a drug target, making it an "incorrect" entry for therapeutic target selection[2][5].

Other names
NF1 pseudogene 4neurofibromin pseudogene 4

Beyond the preview

Go deeper on Neurofibromin 1 pseudogene 4 (NF1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurofibromin 1 pseudogene 4 (NF1P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call